Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-31 Purchase | 2023-09-08 5:47 pm | Arch Therapeutics Inc. | ARTH | ABRAMS MICHAEL S CHIEF FINANCIAL OFFICER | 10,292 | $0.275 | $2,830 | 30,876 (Direct) | View |
| 2023-08-31 Purchase | 2023-09-08 5:47 pm | Arch Therapeutics Inc. | ARTH | Norchi Terrence W PRESIDENT AND CHIEF EXECUTIVE | 6,862 | $0.275 | $1,887 | 20,586 (Direct) | View |
| 2023-08-31 Purchase | 2023-09-08 5:47 pm | Arch Therapeutics Inc. | ARTH | Hicks Laurence Director | 10,292 | $0.275 | $2,830 | 30,876 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-08-31 Option Award | 2023-09-08 5:47 pm | N/A 2028-08-31 | Arch Therapeutics Inc. | ARTH | ABRAMS MICHAEL S CHIEF FINANCIAL OFFICER | 20,584 | $0 | 30,876 (Direct) | View |
| 2023-08-31 Option Award | 2023-09-08 5:47 pm | N/A 2028-08-31 | Arch Therapeutics Inc. | ARTH | Norchi Terrence W PRESIDENT AND CHIEF EXECUTIVE | 13,724 | $0 | 20,586 (Direct) | View |
| 2023-08-31 Option Award | 2023-09-08 5:47 pm | N/A 2028-08-31 | Arch Therapeutics Inc. | ARTH | Hicks Laurence Director | 20,584 | $0 | 30,876 (Indirect) | View |
| 2022-11-10 Option Award | 2022-11-10 9:54 pm | N/A 2032-11-10 | Arch Therapeutics Inc. | ARTH | DHILLON PUNIT Director | 250,000 | $0 | 250,000 (Direct) | View |
| 2022-11-10 Option Award | 2022-11-10 9:52 pm | N/A 2032-11-10 | Arch Therapeutics Inc. | ARTH | Fish Guy L. Director | 250,000 | $0 | 250,000 (Direct) | View |
| 2022-11-10 Option Award | 2022-11-10 9:51 pm | N/A 2032-11-10 | Arch Therapeutics Inc. | ARTH | Hicks Laurence Director | 250,000 | $0 | 250,000 (Direct) | View |
| 2022-11-10 Option Award | 2022-11-10 9:50 pm | N/A 2032-11-10 | Arch Therapeutics Inc. | ARTH | Yrigoyen Dan VICE PRESIDENT, SALES | 500,000 | $0 | 500,000 (Direct) | View |
| 2022-11-10 Option Award | 2022-11-10 9:50 pm | N/A 2032-11-10 | Arch Therapeutics Inc. | ARTH | Norchi Terrence W PRESIDENT AND CHIEF EXECUTIVE | 1,250,000 | $0 | 1,250,000 (Direct) | View |
| 2022-11-10 Option Award | 2022-11-10 9:49 pm | N/A 2032-11-10 | Arch Therapeutics Inc. | ARTH | ABRAMS MICHAEL S CHIEF FINANCIAL OFFICER | 900,000 | $0 | 900,000 (Direct) | View |
| 2022-07-06 Option Award | 2022-07-08 4:57 pm | N/A N/A | Arch Therapeutics Inc. | ARTH | ABRAMS MICHAEL S CHIEF FINANCIAL OFFICER | 868,998 | $0 | 868,998 (Direct) | View |
| 2022-07-06 Option Award | 2022-07-08 4:55 pm | N/A N/A | Arch Therapeutics Inc. | ARTH | Norchi Terrence W PRESIDENT AND CHIEF EXECUTIVE | 579,332 | $0 | 13,488,409 (Direct) | View |
| 2022-07-06 Option Award | 2022-07-08 4:53 pm | N/A N/A | Arch Therapeutics Inc. | ARTH | Hicks Laurence Director | 868,998 | $0 | 868,998 (Direct) | View |
| 2022-05-24 Option Award | 2022-06-09 6:21 pm | N/A 2032-05-23 | Arch Therapeutics Inc. | ARTH | Yrigoyen Dan VICE PRESIDENT, SALES | 150,000 | $0 | 150,000 (Direct) | View |
| 2021-12-31 Option Award | 2022-01-04 4:17 pm | N/A 2031-12-31 | Arch Therapeutics Inc. | ARTH | Fish Guy L. Director | 250,000 | $0 | 250,000 (Direct) | View |
| 2021-09-27 Option Award | 2021-10-13 06:03 am | N/A 2031-09-26 | Arch Therapeutics Inc. | ARTH | Hicks Laurence Director | 250,000 | $0 | 250,000 (Direct) | View |
Ownership | 2021-10-12 9:23 pm | N/A N/A | Arch Therapeutics Inc. | ARTH | Hicks Laurence Director | 0 | $0 | 527,273 (Indirect) | View |
| 2021-09-27 Option Award | 2021-10-01 08:21 am | N/A 2031-09-26 | Arch Therapeutics Inc. | ARTH | Yrigoyen Dan Vice President, Sales | 200,000 | $0 | 200,000 (Direct) | View |
| 2021-09-27 Option Award | 2021-10-01 08:17 am | N/A 2031-09-26 | Arch Therapeutics Inc. | ARTH | ABRAMS MICHAEL S Chief Financial Officer | 350,000 | $0 | 350,000 (Direct) | View |
| 2021-09-27 Option Award | 2021-10-01 08:14 am | N/A 2031-09-26 | Arch Therapeutics Inc. | ARTH | SULAT JAMES R Director | 500,000 | $0 | 500,000 (Direct) | View |
| 2021-09-27 Option Award | 2021-10-01 08:11 am | N/A 2031-09-26 | Arch Therapeutics Inc. | ARTH | DHILLON PUNIT Director | 500,000 | $0 | 500,000 (Direct) | View |
| 2021-09-27 Option Award | 2021-10-01 08:06 am | N/A 2031-09-26 | Arch Therapeutics Inc. | ARTH | Norchi Terrence W President, CEO and Director | 2,000,000 | $0 | 2,000,000 (Direct) | View |
| 2021-07-30 Option Award | 2021-08-11 5:17 pm | N/A 2031-07-29 | Arch Therapeutics Inc. | ARTH | Yrigoyen Dan Vice President, Sales | 150,000 | $0 | 300,000 (Direct) | View |
Ownership | 2021-05-10 08:02 am | N/A 2031-05-02 | Arch Therapeutics Inc. | ARTH | ABRAMS MICHAEL S CFO and Treasurer | 0 | $0 | 500,000 (Direct) | View |
| 2020-06-22 Exercise | 2020-06-23 07:59 am | N/A N/A | Arch Therapeutics Inc. | ARTH | SULAT JAMES R Director | 454,546 | $0.18 | 2,087,723 (Indirect) | View |
| 2020-06-22 Exercise | 2020-06-23 07:59 am | 2015-06-30 2020-06-30 | Arch Therapeutics Inc. | ARTH | SULAT JAMES R Director | 454,546 | $0 | 2,087,723 (Indirect) | View |